Odence-Ford Marion — SEC insider filings
SEC reporting owner CIK 1845002. 30 insider filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2021-02-12 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 1,000 shares, $15,750 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 4,000 shares, $60,751 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 65.
- Largest priced transaction: sale of 4,000 shares @ $15.19 ($60,751) in OptimizeRx Corp, filed 2024-01-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptimizeRx Corp (OPRX) | Chief Legal & Admin Officer | 30 | 1 leg · 1,000 sh · $15,750 | 1 leg · 4,000 sh · $60,751 | 65 |
Insider filings — Odence-Ford Marion
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 1,529 @ $7.71 | EDGAR |
| 2026-08-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 57,600 @ $0 | EDGAR |
| 2026-02-13 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 4,000 · Tax withholding (F): 1,386 @ $9.23 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 4,051 @ $12.74 | EDGAR |
| 2025-12-22 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 3,928 @ $0 · Tax withholding (F): 1,153 @ $13.51 · Option exercise (M): 3,928 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $18.75 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 15,625 @ $0 · Grant/award (A): 35,156 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $5.18 · Option exercise (M): 771 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | OptimizeRx Corp (OPRX) | Tax withholding (F): 1,479 @ $6.64 | EDGAR |
| 2025-02-13 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 4,000 · Tax withholding (F): 1,386 @ $5.60 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 41,408 @ $0 · Grant/award (A): 77,742 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 3,927 @ $0 · Tax withholding (F): 1,153 @ $4.75 · Option exercise (M): 3,927 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,785 @ $0 · Tax withholding (F): 524 @ $6.27 · Option exercise (M): 1,785 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $7.83 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 4,267 @ $0 | EDGAR |
| 2024-03-06 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $15.95 · Option exercise (M): 771 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 11,783 (derivative) @ $0 · Grant/award (A): 11,783 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,386 @ $15.39 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | OptimizeRx Corp (OPRX) | Sale (S): 4,000 @ $15.19 | EDGAR |
| 2023-11-13 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,785 @ $0 · Tax withholding (F): 524 @ $9.21 · Option exercise (M): 1,785 (derivative) @ $0 | EDGAR |
| 2023-10-06 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 6,649 @ $0 · Tax withholding (F): 1,952 @ $7.06 · Option exercise (M): 6,649 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 771 @ $0 · Tax withholding (F): 268 @ $18.11 · Option exercise (M): 771 (derivative) @ $0 | EDGAR |
| 2023-02-14 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,422 @ $17.34 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2022-11-10 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 1,785 @ $0 · Tax withholding (F): 710 @ $14.52 · Option exercise (M): 1,785 (derivative) @ $0 | EDGAR |
| 2022-10-05 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 19,947 (derivative) @ $0 · Grant/award (A): 39,055 (derivative) @ $0 | EDGAR |
| 2022-08-30 | 4 | OptimizeRx Corp (OPRX) | Purchase (P): 1,000 @ $15.75 | EDGAR |
| 2022-03-03 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 4,690 (derivative) @ $0 · Grant/award (A): 2,313 (derivative) @ $0 | EDGAR |
| 2022-02-15 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 10,958 (derivative) @ $0 · Grant/award (A): 5,355 (derivative) @ $0 | EDGAR |
| 2021-02-12 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 20,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-12 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1845002 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs